Personalize our approach to diagnosis and treatment and potentially change the way we manage patients with chronic obstructive pulmonary disease (COPD) with the ultimate goal of improving clinical outcomes and supporting ongoing discovery.


Better understand COPD characteristics and health outcomes to more effectively manage and improve the care of individuals living with COPD.

Chronic Obstructive Pulmonary Disease Research and Precision Medicine

Questions we're asking that inform us on how to best care for patients include:

Improving Outcomes

Are there specific projects or pragmatic clinical trials we can drive to improve health and/or reduce costs for COPD patients?


Identifying Subgroups

Can novel COPD subgroups with distinct clinical trajectories, biological underpinnings, or poor outcomes be identified through this research?

DNA strand

Comprehensive Research

Can we build a comprehensive research program that provides for integration and evaluation of emerging therapies into our clinical treatment centers?

circles biology icon

Clinical Trials

An important part of our mission is to advance state-of-the-art patient care through research. Biomedical research distinguishes an academic medical center from other hospitals, and the Division of Pulmonary & Critical Care Medicine is further distinguished by the breadth and depth of our research program.

Patient Care for Chronic Obstructive Pulmonary Disease

Our clinical mission is to provide state-of-the-art patient care of the highest quality and compassion. We fulfill this mission for our patients across the spectrum of illness, from outpatients to the critically ill, whose health challenges inspire our research efforts and whose experiences serve as our classroom. Find out more about patient care for obstructive lung disease.

Johns Hopkins School of Medicine Joins Partnership to Advance Precision Medicine

Collaboration between Bloomberg Philanthropies, the Johns Hopkins University School of Medicine, and the New York Stem Cell Foundation Research Institute will provide an unmatched scope of resources and expertise to study and develop targeted therapies for diseases.

Read the Article